83 related articles for article (PubMed ID: 22885958)
21. Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 1. A new strategy for generation of anti-carbohydrate antibodies.
Sakai K; Shimizu Y; Chiba T; Matsumoto-Takasaki A; Kusada Y; Zhang W; Nakata M; Kojima N; Toma K; Takayanagi A; Shimizu N; Fujita-Yamaguchi Y
Biochemistry; 2007 Jan; 46(1):253-62. PubMed ID: 17198396
[TBL] [Abstract][Full Text] [Related]
22. Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 2. Expression, purification, and characterization of recombinant single chain antibodies.
Zhang W; Matsumoto-Takasaki A; Kusada Y; Sakaue H; Sakai K; Nakata M; Fujita-Yamaguchi Y
Biochemistry; 2007 Jan; 46(1):263-70. PubMed ID: 17198397
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
Fuhler GM; Baanstra M; Chesik D; Somasundaram R; Seckinger A; Hose D; Peppelenbosch MP; Bos NA
Exp Cell Res; 2010 Jul; 316(11):1816-28. PubMed ID: 20307537
[TBL] [Abstract][Full Text] [Related]
24. Anti-human CD138 monoclonal antibodies and their bispecific formats: generation and characterization.
Chen D; Zou J; Zong Y; Meng H; An G; Yang L
Immunopharmacol Immunotoxicol; 2016 Jun; 38(3):175-83. PubMed ID: 26954291
[TBL] [Abstract][Full Text] [Related]
25. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney.
van Kuppevelt TH; Dennissen MA; van Venrooij WJ; Hoet RM; Veerkamp JH
J Biol Chem; 1998 May; 273(21):12960-6. PubMed ID: 9582329
[TBL] [Abstract][Full Text] [Related]
26. The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2.
Arlov Ø; Aachmann FL; Feyzi E; Sundan A; Skjåk-Bræk G
Biomacromolecules; 2015 Nov; 16(11):3417-24. PubMed ID: 26406104
[TBL] [Abstract][Full Text] [Related]
27. Syndecan-1 and stromal heparan sulfate proteoglycans: key moderators of plasma cell biology and myeloma pathogenesis.
Ren Z; Spaargaren M; Pals ST
Blood; 2021 Apr; 137(13):1713-1718. PubMed ID: 33512430
[TBL] [Abstract][Full Text] [Related]
28. Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma.
Reijmers RM; Groen RW; Rozemuller H; Kuil A; de Haan-Kramer A; Csikós T; Martens AC; Spaargaren M; Pals ST
Blood; 2010 Jan; 115(3):601-4. PubMed ID: 19965677
[TBL] [Abstract][Full Text] [Related]
29. The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.
Yang Y; MacLeod V; Dai Y; Khotskaya-Sample Y; Shriver Z; Venkataraman G; Sasisekharan R; Naggi A; Torri G; Casu B; Vlodavsky I; Suva LJ; Epstein J; Yaccoby S; Shaughnessy JD; Barlogie B; Sanderson RD
Blood; 2007 Sep; 110(6):2041-8. PubMed ID: 17536013
[TBL] [Abstract][Full Text] [Related]
30. Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.
Thompson SM; Fernig DG; Jesudason EC; Losty PD; van de Westerlo EM; van Kuppevelt TH; Turnbull JE
J Biol Chem; 2009 Dec; 284(51):35621-31. PubMed ID: 19837661
[TBL] [Abstract][Full Text] [Related]
31. Novel heparan sulfate structures revealed by monoclonal antibodies.
van den Born J; Salmivirta K; Henttinen T; Ostman N; Ishimaru T; Miyaura S; Yoshida K; Salmivirta M
J Biol Chem; 2005 May; 280(21):20516-23. PubMed ID: 15778504
[TBL] [Abstract][Full Text] [Related]
32. 3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness.
Baert L; Manfroi B; Quintero M; Chavarria O; Barbon PV; Clement E; Zeller A; Van Kuppevelt T; Sturm N; Moreaux J; Tveita A; Bogen B; McKee T; Huard B
Matrix Biol; 2023 Jun; 120():60-75. PubMed ID: 37201729
[TBL] [Abstract][Full Text] [Related]
33. Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.
Bret C; Hose D; Reme T; Sprynski AC; Mahtouk K; Schved JF; Quittet P; Rossi JF; Goldschmidt H; Klein B
Br J Haematol; 2009 May; 145(3):350-68. PubMed ID: 19298595
[TBL] [Abstract][Full Text] [Related]
34. Tailoring subtractive cell biopanning to identify diffuse gastric adenocarcinoma-associated antigens via human scFv antibodies.
Mehdipour T; Tohidkia MR; Ata Saei A; Kazemi A; Khajeh S; Rahim Rahimi AA; Nikfarjam S; Farhadi M; Halimi M; Soleimani R; Zubarev RA; Nouri M
Immunology; 2020 Jan; 159(1):96-108. PubMed ID: 31596953
[TBL] [Abstract][Full Text] [Related]
35. Shed syndecan-1 translocates to the nucleus of cells delivering growth factors and inhibiting histone acetylation: a novel mechanism of tumor-host cross-talk.
Stewart MD; Ramani VC; Sanderson RD
J Biol Chem; 2015 Jan; 290(2):941-9. PubMed ID: 25404732
[TBL] [Abstract][Full Text] [Related]
36. Developing and characterization of single chain variable fragment (scFv) antibody against frizzled 7 (Fzd7) receptor.
Nickho H; Younesi V; Aghebati-Maleki L; Motallebnezhad M; Majidi Zolbanin J; Movassagh Pour A; Yousefi M
Bioengineered; 2017 Sep; 8(5):501-510. PubMed ID: 27849134
[TBL] [Abstract][Full Text] [Related]
37. Syndecan-1: a dynamic regulator of the myeloma microenvironment.
Sanderson RD; Yang Y
Clin Exp Metastasis; 2008; 25(2):149-59. PubMed ID: 18027090
[TBL] [Abstract][Full Text] [Related]
38. A transgenic approach to live imaging of heparan sulfate modification patterns.
Attreed M; Bülow HE
Methods Mol Biol; 2015; 1229():253-68. PubMed ID: 25325959
[TBL] [Abstract][Full Text] [Related]
39. Antibody Surface Profiling Identifies Glycoforms in Multiple Myeloma as Targets for Immunotherapy: From Antibody Derivatives to Mimetic Peptides for Killing Tumor Cells.
Sioud M; Olberg A
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046595
[TBL] [Abstract][Full Text] [Related]
40. A mutant-cell library for systematic analysis of heparan sulfate structure-function relationships.
Qiu H; Shi S; Yue J; Xin M; Nairn AV; Lin L; Liu X; Li G; Archer-Hartmann SA; Dela Rosa M; Galizzi M; Wang S; Zhang F; Azadi P; van Kuppevelt TH; Cardoso WV; Kimata K; Ai X; Moremen KW; Esko JD; Linhardt RJ; Wang L
Nat Methods; 2018 Nov; 15(11):889-899. PubMed ID: 30377379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
